Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Announces Launch of Nebivolol Tablets

Business Wire September 17, 2021

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome

Business Wire August 31, 2021

ANI Pharmaceuticals Reports Second Quarter 2021 Results

Business Wire August 6, 2021

ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021

Business Wire July 22, 2021

ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA

Business Wire July 6, 2021

ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021

Business Wire June 15, 2021

ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders

Business Wire June 1, 2021

ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021

Business Wire May 27, 2021

ANI Pharmaceuticals Reports First Quarter 2021 Results

Business Wire May 7, 2021

ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021

Business Wire April 26, 2021

ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs

Business Wire April 6, 2021

ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth

Business Wire March 9, 2021

ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business

Business Wire March 9, 2021

ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire February 19, 2021

ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth

Business Wire February 17, 2021

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021

Business Wire February 16, 2021

ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride ("HCl") Capsules

Business Wire February 1, 2021

ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets

Business Wire December 17, 2020

ANI Pharmaceuticals Reports Third Quarter 2020 Results

Business Wire November 5, 2020

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results

Business Wire October 29, 2020